[
  {
    "ts": null,
    "headline": "The Year’s Biggest Deal Could Yield a Record Payout for Bank of America",
    "summary": "The bank stands to earn $130 million for work on the railroad megadeal between Union Pacific and Norfolk Southern.",
    "url": "https://finnhub.io/api/news?id=fb14a26ca01d8380804690826bf375d9968cbc037288a9ed13b3d873b010248b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758364200,
      "headline": "The Year’s Biggest Deal Could Yield a Record Payout for Bank of America",
      "id": 136828155,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The bank stands to earn $130 million for work on the railroad megadeal between Union Pacific and Norfolk Southern.",
      "url": "https://finnhub.io/api/news?id=fb14a26ca01d8380804690826bf375d9968cbc037288a9ed13b3d873b010248b"
    }
  },
  {
    "ts": null,
    "headline": "H.C. Wainwright Affirms ‘Buy’ Rating on Atai Life Sciences N.V. (ATAI) on Psychedelic Prospects",
    "summary": "Atai Life Sciences N.V. (NASDAQ:ATAI) is one of the best healthcare penny stocks to buy now. On September 15, H.C. Wainwright reiterated a ‘Buy’ rating on the stock and a $15 price target. The positive stance follows a meeting between the research firm and the company’s CEO, Srinivas Rao, at the 27th Annual Global Investment […]",
    "url": "https://finnhub.io/api/news?id=e1c33f432188868c559a02f12ac8c7f53f761adb0602f634578e62e60c89c467",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758354203,
      "headline": "H.C. Wainwright Affirms ‘Buy’ Rating on Atai Life Sciences N.V. (ATAI) on Psychedelic Prospects",
      "id": 136828156,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Atai Life Sciences N.V. (NASDAQ:ATAI) is one of the best healthcare penny stocks to buy now. On September 15, H.C. Wainwright reiterated a ‘Buy’ rating on the stock and a $15 price target. The positive stance follows a meeting between the research firm and the company’s CEO, Srinivas Rao, at the 27th Annual Global Investment […]",
      "url": "https://finnhub.io/api/news?id=e1c33f432188868c559a02f12ac8c7f53f761adb0602f634578e62e60c89c467"
    }
  }
]